Edition:
India

Oxford Immunotec Global PLC (OXFD.OQ)

OXFD.OQ on NASDAQ Stock Exchange Global Market

14.27USD
15 Dec 2017
Change (% chg)

$0.52 (+3.78%)
Prev Close
$13.75
Open
$13.75
Day's High
$14.52
Day's Low
$13.75
Volume
227,739
Avg. Vol
39,624
52-wk High
$19.50
52-wk Low
$12.20

Chart for

About

Oxford Immunotec Global PLC is a diagnostics company. The Company is focused on developing and commercializing tests for under-served immune-regulated conditions. The Company's product lines and development activities principally focus on four areas: infectious diseases, transplantation, autoimmune and inflammatory disease and... (more)

Overall

Beta: -0.09
Market Cap(Mil.): $427.87
Shares Outstanding(Mil.): 25.51
Dividend: --
Yield (%): --

Financials

BRIEF-Oxford Immunotec And Qiagen Reached A Settlement In Lawsuit

* OXFORD IMMUNOTEC GLOBAL - CO, QIAGEN REACHED A SETTLEMENT IN LAWSUIT IN U.S. COURT ALLEGING PATENT INFRINGEMENT IN RELATION TO QIAGEN'S PRODUCTS

16 Dec 2017

BRIEF-Oxford Immunotec Global Plc says unit entered into a 2nd amendment to purchase agreement with Mabtech AB​

* Oxford Immunotec Global Plc - ‍on Nov 17, unit entered into a second amendment to purchase agreement with Mabtech AB​

22 Nov 2017

BRIEF-Oxford Immunotec Global Q3 loss per share $0.70

* Oxford Immunotec reports third quarter 2017 financial results

31 Oct 2017

BRIEF-Oxford Immunotec announces update in patent infringement litigation

* Oxford Immunotec announces update in patent infringement litigation

27 Sep 2017

BRIEF-Oxford Immunotec updates on amendment to supply agreement with StemCell Technologies ​

* Oxford Immunotec Global PLC - ‍on Sept 1 unit entered into second amendment to supply agreement with StemCell Technologies Canada f/k/a StemCell Technologies ​

07 Sep 2017

BRIEF-Oxford Immunotec appoints Stefan Linn as COO

* Oxford Immunotec appoints Stefan Linn as chief operating officer Source text for Eikon: Further company coverage:

30 Aug 2017

BRIEF-Oxford Immunotec Global Plc announces pricing of underwritten public offering of ordinary shares

* Oxford Immunotec Global Plc announces pricing of underwritten public offering of ordinary shares

15 Aug 2017

BRIEF-Oxford Immunotec Global announces agreement to sell 2.5 mln ordinary shares

* Oxford Immunotec Global Plc announces agreement to sell 2,500,000 ordinary shares

15 Aug 2017

BRIEF-Oxford Immunotec Q2 loss per share $0.74

* Oxford immunotec reports second quarter 2017 financial results

01 Aug 2017

BRIEF-Oxford Immunotec Global says unit entered into amendment to marketing authorization holder agreement with Riken Genesis

* Oxford Immunotec Global Plc - on july 24, unit of co entered into amendment to marketing authorization holder agreement with Riken Genesis Co., Ltd

29 Jul 2017

Competitors

  Price Chg
Thermo Fisher Scientific Inc. (TMO.N) $192.27 +3.95
Bruker Corporation (BRKR.OQ) $34.63 +0.73
STERIS Corp (STE.N) $89.19 +1.62

Earnings vs. Estimates